journal
https://read.qxmd.com/read/38644716/applications-of-l-arginine-in-pregnancy-and-beyond-an-emerging-pharmacogenomic-approach
#1
JOURNAL ARTICLE
Sai Vaishnavi V, Mahadevamma Lingaiah, Bala Murali Mohan Sanku, Sunil Kumar Kadri, Manoj Kumar Mudigubba
L-arginine is a semi-essential amino acid that plays a critical role in various physiological processes, such as protein synthesis, wound healing, immune function, and cardiovascular regulation. The use of L-arginine in pregnancy has been an emerging topic in the field of pharmacogenomics. L-arginine, an amino acid, plays a crucial role in the production of nitric oxide, which is necessary for proper placental development and fetal growth. Studies have shown that L-arginine supplementation during pregnancy can have positive effects on fetal growth, maternal blood pressure, and the prevention of preeclampsia...
April 19, 2024: Current Gene Therapy
https://read.qxmd.com/read/38623982/evolution-of-prime-editing-systems-move-forward-to-the-treatment-of-hereditary-diseases
#2
JOURNAL ARTICLE
Olga V Volodina, Anastasia R Fabrichnikova, Arina A Anuchina, Olesya S Mishina, Alexander V Lavrov, Svetlana A Smirnikhina
The development of gene therapy using genome editing tools recently became relevant. With the invention of programmable nucleases, it became possible to treat hereditary diseases due to introducing targeted double strand break in the genome followed by homology directed repair (HDR) or non-homologous end-joining (NHEJ) reparation. CRISPR-Cas9 is more efficient and easier to use in comparison with other programmable nucleases. To improve the efficiency and safety of this gene editing tool, various modifications CRISPR-Cas9 basis were created in recent years, such as prime editing - in this system, Cas9 nickase is fused with reverse transcriptase and guide RNA, which contains a desired correction...
April 15, 2024: Current Gene Therapy
https://read.qxmd.com/read/38529607/gene-therapy-for-skin-aging
#3
JOURNAL ARTICLE
Fawzy A Saad
Extrinsic and intrinsic factors contribute to skin aging; nonetheless, they are intertwined. Moreover, intrinsic skin aging mirrors age-related declines in the entire human body's internal organs. There is evidence that skin appearance is an indicator of the general health of somebody. Earlier, it was apparent that the intrinsic factors are unalterable, but the sparkling of skin aging gene therapy on the horizon is changing this narrative. Skin aging gene therapy offers tools for skin rejuvenation and, natural beauty restoration, and therapy for diseases affecting the entire skin...
March 25, 2024: Current Gene Therapy
https://read.qxmd.com/read/38441026/znf695-a-potential-prognostic-biomarker-correlates-with-immune-infiltrates-in-cervical-squamous-cell-carcinoma-and-endocervical-adenocarcinoma-bioinformatic-analysis-and-experimental-verification
#4
JOURNAL ARTICLE
Xiaojuan Ding, Ailing Wan, Xin Qi, Ke'er Jiang, Zhao Liu, Buze Chen
BACKGROUND: The role of Zinc Finger Protein 695 (ZNF695) is unclear in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC). OBJECTIVE: The objective of this study was to conduct a comprehensive analysis and experimental validation of ZNF695 in CESC. METHODS: The study investigated the expression of ZNF695 in both pan-cancer and CESC, utilizing data from The Cancer Genome Atlas (TCGA) database to assess its diagnostic value...
March 1, 2024: Current Gene Therapy
https://read.qxmd.com/read/38288826/current-landscape-of-gene-therapy-for-the-treatment-of-cardiovascular-disorders
#5
JOURNAL ARTICLE
Pranay Wal, Namra Aziz, Chetan Pratap Singh, Azhar Rasheed, Lalit Kumar Tyagi, Ankur Agrawal, Ankita Wal
Cardiovascular disorders (CVD) are the primary cause of death worldwide. Multiple factors have been accepted to cause cardiovascular diseases; among them, smoking, physical inactivity, unhealthy eating habits, age, and family history are flag-bearers. Individuals at risk of developing CVD are suggested to make drastic habitual changes as the primary intervention to prevent CVD; however, over time, the disease is bound to worsen. This is when secondary interventions come into play, including antihypertensive, anti-lipidemic, anti-anginal, and inotropic drugs...
January 29, 2024: Current Gene Therapy
https://read.qxmd.com/read/38284735/hemophilia-healing-with-aav-navigating-the-frontier-of-gene-therapy
#6
JOURNAL ARTICLE
Safir Ullah Khan, Munir Ullah Khan, Muhammad Suleman, Amrah Inam, Muhammad Azhar Ud Din
Gene therapy for hemophilia has advanced tremendously after thirty years of continual study and development. Advancements in medical science have facilitated attaining normal levels of Factor VIII (FVIII) or Factor IX (FIX) in individuals with haemophilia, thereby offering the potential for their complete recovery. Despite the notable advancements in various countries, there is significant scope for further enhancement in haemophilia gene therapy. Adeno-associated virus (AAV) currently serves as the primary vehicle for gene therapy in clinical trials targeting haemophilia...
January 26, 2024: Current Gene Therapy
https://read.qxmd.com/read/38258771/precision-genome-editing-techniques-in-gene-therapy-current-state-and-future-prospects
#7
JOURNAL ARTICLE
Kuldeep Singh, Bharat Bhushan, Sunil Kumar, Supriya Singh, Romulo R Macadangdang, Ekta Pandey, Ajit Kumar Varma, Shivendra Kumar
Precision genome editing is a rapidly evolving field in gene therapy, allowing for the precise modification of genetic material. The CRISPR and Cas systems, particularly the CRISPR-- Cas9 system, have revolutionized genetic research and therapeutic development by enabling precise changes like single-nucleotide substitutions, insertions, and deletions. This technology has the potential to correct disease-causing mutations at their source, allowing for the treatment of various genetic diseases. Programmable nucleases like CRISPR-Cas9, transcription activator-like effector nucleases (TALENs), and zinc finger nucleases (ZFNs) can be used to restore normal gene function, paving the way for novel therapeutic interventions...
January 22, 2024: Current Gene Therapy
https://read.qxmd.com/read/38310455/potential-therapeutic-approach-using-aromatic-l-amino-acid-decarboxylase-and-glial-derived-neurotrophic-factor-therapy-targeting-putamen-in-parkinson-s-disease
#8
JOURNAL ARTICLE
Raman Kumar Tripathi, Lav Goyal, Shamsher Singh
Parkinson's disease (PD) is a neurodegenerative illness characterized by specific loss of dopaminergic neurons, resulting in impaired motor movement. Its prevalence is twice as compared to the previous 25 years and affects more than 10 million individuals. Lack of treatment still uses levodopa and other options as disease management measures. Treatment shifts to gene therapy (GT), which utilizes direct delivery of specific genes at the targeted area. Therefore, the use of aromatic L-amino acid decarboxylase (AADC) and glial-derived neurotrophic factor (GDNF) therapy achieves an effective control to treat PD...
January 19, 2024: Current Gene Therapy
https://read.qxmd.com/read/38310459/direct-bilirubin-but-not-indirect-bilirubin-is-associated-with-short-term-adverse-events-in-hfpef
#9
JOURNAL ARTICLE
Sunying Wang, Yan Chen, Hanghao Ma, Yuwei Wang, Manqing Luo, Xianwei Xie, Qingyong Yang, Kaijin Lin, Meihua Lin, Lin Lin, Ping Chen, Qiaowen Zheng, Fuqing Sun
Abnormal live function tests have been identified as independent risk factors for ominous prognosis in patients with heart failure. However, most of the previous studies have failed to determine the contribution of direct bilirubin (DBIL) and indirect bilirubin (IBIL) separately. Hence, we aimed to explore whether DBIL or IBIL is correlated with the prognosis of heart failure with preserved ejection fraction (HFpEF). <p> Methods: A total of 19837 patients were hospitalized for HFpEF between January 2012 and January 2022 in Fuqing City Hospital affiliated with Fujian Medical University...
January 16, 2024: Current Gene Therapy
https://read.qxmd.com/read/38310458/segmentation-of-thoracic-organs-through-distributed-extraction-of-visual-feature-patterns-utilizing-resio-inception-u-net-and-deep-cluster-recognition-techniques
#10
JOURNAL ARTICLE
Karthikeyan S, Tathagat Banerjee, Devi Priya, Meenalosini Vimal Cruz
Segmentation of medical images plays a key role in the correct identification and management of different diseases. In this study, we present a new segmentation method that meets the difficulties posed by sophisticated organ shapes in computed tomography (CT) images, particularly targeting lung, breast, and gastric cancers. Our suggested methods, Resio-Inception U-Net and Deep Cluster Recognition (RIUDCR), use a Residual Inception Architecture, which combines the power of residual connections and inception blocks to achieve cutting-edge segmentation performance while reducing the risk of overfitting...
January 2, 2024: Current Gene Therapy
https://read.qxmd.com/read/38310457/therapeutic-potential-of-crispr-cas-in-hashimoto-s-thyroiditis-a-comprehensive-review
#11
JOURNAL ARTICLE
Apoorva Upreeti, Sayali Mukherjee
Hashimoto's thyroiditis (HT) is a commonly occurring illness of autoimmune endocrine origin. It is usually present in the pediatric age group along with other well-known diseases, such as type 1 insulin-dependent diabetes. The defining feature of this disease is the immune-- mediated attack on the thyroid gland resulting in the destruction of thyroid tissues and cells. Given that HT frequently affects family members, it is well-recognized that individuals are genetically predisposed to this disease. Patients with HT also display a significantly increased risk for several different cancers, justifying the eminent need for the development of therapies for managing and treating HT...
January 2, 2024: Current Gene Therapy
https://read.qxmd.com/read/38310456/crispr-based-therapies-revolutionizing-drug-development-and-precision-medicine
#12
JOURNAL ARTICLE
Dilip Kumar Chanchal, Jitendra Singh Chaudhary, Pushpendra Kumar, Neha Agnihotri, Prateek Porwal
With the discovery of CRISPR-Cas9, drug development and precision medicine have undergone a major change. This review article looks at the new ways that CRISPR-based therapies are being used and how they are changing the way medicine is done. CRISPR technology's ability to precisely and flexibly edit genes has opened up new ways to find, validate, and develop drug targets. Also, it has made way for personalized gene therapies, precise gene editing, and advanced screening techniques, all of which hold great promise for treating a wide range of diseases...
January 2, 2024: Current Gene Therapy
https://read.qxmd.com/read/38282448/splicing-dna-damage-adaptations-for-the-management-of-cancer-cells
#13
JOURNAL ARTICLE
Arun Kumar Singh, Deepika Yadav, Rishabha Malviya
Maintaining a tumour cell's resistance to apoptosis (organized cell death) is essential for cancer to metastasize. Signal molecules play a critical function in the tightly regulated apoptotic process. Apoptosis may be triggered by a wide variety of cellular stresses, including DNA damage, but its ultimate goal is always the same: the removal of damaged cells that might otherwise develop into tumours. Many chemotherapy drugs rely on cancer cells being able to undergo apoptosis as a means of killing them. The mechanisms by which DNA-damaging agents trigger apoptosis, the interplay between pro- and apoptosis-inducing signals, and the potential for alteration of these pathways in cancer are the primary topics of this review...
2024: Current Gene Therapy
https://read.qxmd.com/read/37957848/prediction-of-sars-cov-2-infection-phosphorylation-sites-and-associations-of-these-modifications-with-lung-cancer-development
#14
JOURNAL ARTICLE
Wei Li, Gen Li, Yuzhi Sun, Liyuan Zhang, Xinran Cui, Yuran Jia, Tianyi Zhao
INTRODUCTION: Since the emergence of SARS-CoV-2 viruses, multiple mutant strains have been identified. Infection with SARS-CoV-2 virus leads to alterations in host cell phosphorylation signal, which systematically modulates the immune response. METHOD: Identification and analysis of SARS-CoV-2 virus infection phosphorylation sites enable insight into the mechanisms of viral infection and effects on host cells, providing important fundamental data for the study and development of potent drugs for the treatment of immune inflammatory diseases...
November 8, 2023: Current Gene Therapy
https://read.qxmd.com/read/37929733/fignl1-promotes-hepatocellular-carcinoma-formation-via-remodeling-ecm-receptor-interaction-pathway-mediated-by-hmmr
#15
JOURNAL ARTICLE
Jiabei Wang, Linmao Sun, Yao Liu, Yunguang Zhang
BACKGROUND: The development of novel biomarkers is crucial for the treatment of HCC. In this study, we investigated a new molecular therapeutic target for HCC. Fidgetin-like 1 (FIGNL1) has been reported to play a vital role in lung adenocarcinoma. However, the potential function of FIGNL1 in HCC is still unknown. OBJECTIVE: This study aims to investigate the key regulatory mechanisms of FIGNL1 in the formation of HCC. METHODS: The regulatory effect of FIGNL1 on HCC was studied by lentivirus infection...
October 31, 2023: Current Gene Therapy
https://read.qxmd.com/read/37921144/applications-of-scaffolds-in-tissue-engineering-current-utilization-and-future-prospective
#16
JOURNAL ARTICLE
Shikha Yadav, Javed Khan, Agrima Yadav
Current regenerative medicine tactics focus on regenerating tissue structures pathologically modified by cell transplantation in combination with supporting scaffolds and biomolecules. Natural and synthetic polymers, bioresorbable inorganic and hybrid materials, and tissue decellularized were deemed biomaterials scaffolding because of their improved structural, mechanical, and biological abilities.Various biomaterials, existing treatment methodologies and emerging technologies in the field of Three-dimensional (3D) and hydrogel processing, and the unique fabric concerns for tissue engineering...
October 26, 2023: Current Gene Therapy
https://read.qxmd.com/read/37921145/vector-mediated-delivery-of-transgenes-and-rna-interference-based-gene-silencing-sequences-to-astrocytes-for-disease-management-advances-and-prospectives
#17
JOURNAL ARTICLE
Deepika Yadav, Rishabha Malviya
Astrocytes are a type of important glial cell in the brain that serve crucial functions in regulating neuronal activity, facilitating communication between neurons, and keeping everything in balance. In this abstract, we explore current methods and future approaches for using vectors to precisely target astrocytes in the fight against various illnesses. In order to deliver therapeutic cargo selectively to astrocytes, researchers have made tremendous progress by using viral vectors such as adeno-associated viruses (AAVs) and lentiviruses...
October 25, 2023: Current Gene Therapy
https://read.qxmd.com/read/37861022/current-updates-on-the-role-of-microrna-in-the-diagnosis-and-treatment-of-neurodegenerative-diseases
#18
JOURNAL ARTICLE
Ammara Saleem, Maira Javaid, Muhammad Furqan Akhtar, Ali Sharif, Bushra Akhtar, Muhammad Naveed, Uzma Saleem, Mirza Muhammad Faran Ashraf Baig, Hafiz Muhammad Zubair, Talha Bin Emran, Mohammad Saleem, Ghulam Md Ashraf
BACKGROUND: MicroRNAs (miRNA) are small noncoding RNAs that play a significant role in the regulation of gene expression. The literature has explored the key involvement of miRNAs in the diagnosis, prognosis, and treatment of various neurodegenerative diseases (NDD), such as Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD). The miRNA regulates various signalling pathways; its dysregulation is involved in the pathogenesis of NDD. OBJECTIVE: The present review is focused on the involvement of miRNAs in the pathogenesis of NDD and their role in the treatment or management of NDD...
October 12, 2023: Current Gene Therapy
https://read.qxmd.com/read/37767800/a-retrospective-analysis-of-the-lauren-classification-in-the-choice-of-xelox-or-sox-as-an-adjuvant-chemotherapy-for-gastric-cancer
#19
JOURNAL ARTICLE
Ke Wang, Yuanyuan Yu, Jian Zhao, Qianhao Meng, Chang Xu, Jing Ren, Yanqiao Zhang, Yusheng Wang, Guangyu Wang
BACKGROUND: We aim to retrospectively explore the guiding value of the Lauren classification for patients who have undergone D2 gastrectomy to choose oxaliplatin plus capecitabine (XELOX) or oxaliplatin plus S-1 (SOX) as a further systemic treatment after the operation. METHODS: We collected data of 406 patients with stage III gastric cancer(GC)after radical D2 resection and regularly received XELOX or SOX adjuvant treatment after surgery and followed them for at least five years...
September 25, 2023: Current Gene Therapy
https://read.qxmd.com/read/37767799/exosome-mir-30a-5p-regulates-glomerular-endothelial-cells-endmt-and-angiogenesis-by-modulating-notch1-vegf-signaling-pathway
#20
JOURNAL ARTICLE
Yaxian Ning, Xiaochun Zhou, Gouqin Wang, Lili Zhang, Jianqin Wang
BACKGROUND: Diabetic nephropathy (DN) is one of the microvascular complications of diabetes. Endothelial-mesenchymal transition (EndMT) and endothelial damage lead to abnormal angiogenesis in DN. OBJECTIVES: This study aimed to investigate the role of exosome miR-30a-5p in high glucose (HG)-induced glomerular endothelial cells (GECs) dysfunction and explore the underlying mechanisms. METHODS: GECs were cultured in normal glucose (5.5 mM) and HG (30 mM) conditions...
September 25, 2023: Current Gene Therapy
journal
journal
39829
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.